These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16525565)

  • 1. D-dimer: standardization versus harmonization.
    Dempfle CE
    Thromb Haemost; 2006 Mar; 95(3):399-400. PubMed ID: 16525565
    [No Abstract]   [Full Text] [Related]  

  • 2. [Does D-dimer help when blood coagulates?].
    Lassila R
    Duodecim; 1999; 115(24):2707-9. PubMed ID: 11979609
    [No Abstract]   [Full Text] [Related]  

  • 3. A model for the harmonisation of test results of different quantitative D-dimer methods.
    Meijer P; Haverkate F; Kluft C; de Moerloose P; Verbruggen B; Spannagl M
    Thromb Haemost; 2006 Mar; 95(3):567-72. PubMed ID: 16525589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of D-dimer testing in patients with venous malformations.
    Maguiness S; Koerper M; Frieden I
    Arch Dermatol; 2009 Nov; 145(11):1321-4. PubMed ID: 19917966
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of the fibrin D-dimer in screening for coagulation abnormalities in preeclampsia.
    Trofatter KF; Howell ML; Greenberg CS; Hage ML
    Obstet Gynecol; 1989 Mar; 73(3 Pt 1):435-40. PubMed ID: 2915868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The harmonization of quantitative test results of different D-dimer methods.
    Meijer P; Kluft C
    Semin Vasc Med; 2005 Nov; 5(4):321-7. PubMed ID: 16302153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoassays for diagnosis of coagulation disorders.
    Kappel A; Ehm M
    Hamostaseologie; 2010 Nov; 30(4):194-201. PubMed ID: 21057714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of fibrinopeptide A and D-dimer in diagnostics of hemostasis disorders].
    Riabov GA; Pasechnik IN; Azizov IuM
    Anesteziol Reanimatol; 2003; (1):69-74. PubMed ID: 12696462
    [No Abstract]   [Full Text] [Related]  

  • 9. [D dimer].
    Kurokawa I; Kimura T; Kondo M; Araki K
    Nihon Rinsho; 1995 Mar; 53 Su Pt 2():34-8. PubMed ID: 8753174
    [No Abstract]   [Full Text] [Related]  

  • 10. Validation, calibration, and specificity of quantitative D-dimer assays.
    Dempfle CE
    Semin Vasc Med; 2005 Nov; 5(4):315-20. PubMed ID: 16302152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
    Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y
    Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical significance of fibrinogen degradation products.
    Bick RL
    Semin Thromb Hemost; 1982 Oct; 8(4):302-30. PubMed ID: 6758120
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnostic of blood coagulation].
    Barthels M
    Hamostaseologie; 2008 Dec; 28(5):320-34. PubMed ID: 19132163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Quantitative evaluation of fibrinogen-fibrin degradation products (FDP) in the blood of full-term newborn infants, using the staphylococcal clumping test].
    Schettini F; Altomare M; Mautone A
    Boll Soc Ital Biol Sper; 1976 Feb; 52(3):121-6. PubMed ID: 949391
    [No Abstract]   [Full Text] [Related]  

  • 15. Validation of an Automated Immunoturbidimetric Assay for Fibrinogen/Fibrin Degradation Products Measurement and its Correlation to a Semi-Quantitative Latex Agglutination Test.
    Martinuzzo ME; Ujhelly C; Barrera LH; Adamo MA; Lopez MS; Otaso JC; Oyhamburu J
    Clin Lab; 2016 Nov; 62(11):2085-2089. PubMed ID: 28164666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent progress on analysis of blood coagulation factors and fibrinolytic agents; FDP D dimer analysis using NANOPIA FDP].
    Matsumoto T; Sakai Y; Maeda M; Takei F
    Rinsho Byori; 1989 Apr; Spec No 81():183-8. PubMed ID: 2754806
    [No Abstract]   [Full Text] [Related]  

  • 17. [A comprehensive laboratory evaluation of changes in the fibrinogen molecule in the diagnosis of acquired coagulopathy conditions].
    Siatkovskiĭ VA; Azarova LA; Vasilenko PL
    Lab Delo; 1989; (8):45-8. PubMed ID: 2477628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D-dimer assays: the current status and new assay technologies.
    Dempfle CE
    Thromb Res; 2006; 118(5):569-71. PubMed ID: 16139335
    [No Abstract]   [Full Text] [Related]  

  • 19. Incidence and clinical significance of elevated fibrin(ogen) degradation product and/or D-dimer levels in liver cirrhosis patients.
    Cioni G; Cristani A; Mussini C; Grandi S; Pentore R; Zeneroli ML; Tizzanini W; Zagni G; Ventura E
    Ital J Gastroenterol; 1990 Apr; 22(2):70-4. PubMed ID: 2131934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation disturbances in cancer of the breast and colon measured with specific monoclonal antibody enzyme immunoassay for fibrin-fibrinogen degradation products.
    McCulloch P; Nieuwenhuizen W; Douglas J; Lowe GD; George WD
    Haemostasis; 1990; 20(2):73-80. PubMed ID: 2189796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.